Marcus Lemonis - 14 May 2026 Form 4 Insider Report for BED BATH & BEYOND, INC. (BBBY)

Reporting relationship: EXECUTIVE CHAIRMAN & CEO, Director
Issuer ticker: BBBY
Reported as of: 14 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:12:11 UTC
Prior SEC filing: 12 Mar 2026
Next SEC filing: 06 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Christina Wheeler, Attorney-in-Fact

Key filing fact

Marcus Lemonis filed Form 4 for BED BATH & BEYOND, INC. (BBBY) on 18 May 2026.

Key facts

This page summarizes Marcus Lemonis's Form 4 filing for BED BATH & BEYOND, INC. (BBBY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2026, 16:12.

Change

Previous filing in this sequence was filed on 12 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001136478 Primary reporting owner

LEMONIS MARCUS

Relationship: EXECUTIVE CHAIRMAN & CEO, Director
Address: 433 ASCENSION WAY, 3RD FLOOR, MURRAY
Signature: /s/ Christina Wheeler, Attorney-in-Fact
Signature date: 18 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBBY transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +1,500,000
Change %
Price: $0.000000^*
Shares after: 1,500,000
Date: 14 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,500,000
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock.

Footnote F2

The restricted stock units were granted on March 11, 2026 subject to shareholder approval, which shareholder approval was received on May 14, 2026.

Footnote F3

The restricted stock units vest in four equal installments at the close of business on January 1, 2027, January 1, 2028, January 1, 2029, and January 1, 2030. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.